MyMD Pharmaceuticals, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
$4.3M
Website

Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/Frailty

First Posted Date
2022-03-17
Last Posted Date
2023-10-30
Lead Sponsor
MyMD Pharmaceuticals, Inc.
Target Recruit Count
40
Registration Number
NCT05283486
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Clinical Research of West Florida, Inc, Clearwater, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Clinical Research of West Florida, Tampa, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Single Ascending and Multiple Dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male and Female Adult Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2021-10-14
Last Posted Date
2023-03-27
Lead Sponsor
MyMD Pharmaceuticals, Inc.
Target Recruit Count
32
Registration Number
NCT05077865
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Clinical Research of West Florida, Inc, Clearwater, Florida, United States

Single Ascending-dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male Adult Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2020-04-16
Last Posted Date
2020-04-16
Lead Sponsor
MyMD Pharmaceuticals, Inc.
Target Recruit Count
40
Registration Number
NCT04349761
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Palm Beach CRO, LLC, West Palm Beach, Florida, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath